Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study
- PMID: 19455012
- PMCID: PMC3156613
- DOI: 10.1097/QAD.0b013e32832d3b85
Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study
Abstract
Background: Cardiovascular disease (CVD) is an increasing cause of morbidity and mortality in HIV-infected patients. However, it is controversial whether HIV infection contributes to accelerated atherosclerosis independent of traditional CVD risk factors.
Methods: Cross-sectional study of HIV-infected participants and controls without pre-existing CVD from the study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM) and the Multi-Ethnic Study of Atherosclerosis (MESA). Preclinical atherosclerosis was assessed by carotid intima-medial thickness (cIMT) measurements in the internal/bulb and common regions in HIV-infected participants and controls after adjusting for traditional CVD risk factors.
Results: For internal carotid, mean IMT was 1.17 +/- 0.50 mm for HIV-infected participants and 1.06 +/- 0.58 mm for controls (P < 0.0001). After multivariable adjustment for demographic characteristics, the mean difference of HIV-infected participants vs. controls was 0.188 mm [95% confidence interval (CI) 0.113-0.263, P < 0.0001]. Further adjustment for traditional CVD risk factors modestly attenuated the HIV association (0.148 mm, 95% CI 0.072-0.224, P = 0.0001). For the common carotid, HIV infection was independently associated with greater IMT (0.033 mm, 95% CI 0.010-0.056, P = 0.005). The association of HIV infection with IMT was similar to that of smoking, which was also associated with greater IMT (internal 0.173 mm, common 0.020 mm).
Conclusion: Even after adjustment for traditional CVD risk factors, HIV infection was accompanied by more extensive atherosclerosis measured by IMT. The stronger association of HIV infection with IMT in the internal/bulb region compared with the common carotid may explain previous discrepancies in the literature. The association of HIV infection with IMT was similar to that of traditional CVD risk factors, such as smoking.
Trial registration: ClinicalTrials.gov NCT00331448.
2009 Wolters Kluwer Health | Lippincott Williams & Wilkins
References
-
- Palella FJ, Jr., Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853–860. - PubMed
-
- Porter K, Babiker A, Bhaskaran K, Darbyshire J, Pezzotti P, Porter K, Walker AS. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet. 2003;362:1267–1274. - PubMed
-
- Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362:22–29. - PubMed
-
- Louie JK, Hsu LC, Osmond DH, Katz MH, Schwarcz SK. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. J Infect Dis. 2002;186:1023–1027. - PubMed
-
- Mocroft A, Brettle R, Kirk O, Blaxhult A, Parkin JM, Antunes F, et al. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. Aids. 2002;16:1663–1671. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
- N01-HC-95162/HC/NHLBI NIH HHS/United States
- M01-RR00083/RR/NCRR NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- R01-HL 53359/HL/NHLBI NIH HHS/United States
- M01 RR000036/RR/NCRR NIH HHS/United States
- K24 AI056933/AI/NIAID NIH HHS/United States
- N01-HC-95159/HC/NHLBI NIH HHS/United States
- M01 RR000054/RR/NCRR NIH HHS/United States
- N01-HC-95160/HC/NHLBI NIH HHS/United States
- R01 HL074814/HL/NHLBI NIH HHS/United States
- M01-RR00865/RR/NCRR NIH HHS/United States
- N01-HC-95161/HC/NHLBI NIH HHS/United States
- K24-AI56933/AI/NIAID NIH HHS/United States
- M01-RR0636/RR/NCRR NIH HHS/United States
- R01-DK57508/DK/NIDDK NIH HHS/United States
- R01 DK057508/DK/NIDDK NIH HHS/United States
- N01-HC-95163/HC/NHLBI NIH HHS/United States
- M01 RR000865/RR/NCRR NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- N01-HC-95165/HC/NHLBI NIH HHS/United States
- K23 AI066943/AI/NIAID NIH HHS/United States
- N01 HC095159/HL/NHLBI NIH HHS/United States
- M01-RR00052/RR/NCRR NIH HHS/United States
- UL1-RR024131/RR/NCRR NIH HHS/United States
- N01-HC-95164/HC/NHLBI NIH HHS/United States
- R01-HL74814/HL/NHLBI NIH HHS/United States
- M01 RR000052/RR/NCRR NIH HHS/United States
- M01 RR000051/RR/NCRR NIH HHS/United States
- M01-RR00051/RR/NCRR NIH HHS/United States
- M01-RR00036/RR/NCRR NIH HHS/United States
- M01-RR00054/RR/NCRR NIH HHS/United States
- N01 HC095165/HL/NHLBI NIH HHS/United States
- M01 RR000083/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
